Anti-Nuclear Matrix Protein p84 antibody [5E10]
5
(16 Reviews)
|
(105 Publications )
- Flow Cyt
Unknown
Flow Cytometry - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
Overlay histogram showing HeLa cells stained with ab487 (red line). The cells were fixed with 100% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab487, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
This image was generated using the ascites version of the product.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
Immunocytochemical analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling Nuclear Matrix Protein p84 at the nucleus with ab487 at 1/500 dilution. Red : phalloidin, a cytoskeleton marker, diluted at 1 : 100.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
Immunohistochemical analysis of human breast carcinoma tissue labeling Nuclear Matrix Protein p84 at the nucleus with ab487 at 1/200 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
Immunohistochemical analysis of human lung cancer tissue labeling Nuclear Matrix Protein p84 at the nucleus with ab487 at 1/100 dilution.
- ICC/IF
AbReview15760****
Immunocytochemistry/ Immunofluorescence - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
ab487 staining Nuclear Matrix Protein p84 in Human stomach adenocarcinoma cell line (AGS) by Immunocytochemistry/ Immunofluorescence. The cells were formaldehyde fixed, permeabilised in 0.025% Triton X-100, TBS and then blocked using 5% serum for 1 hour at 23°C. Samples were then incubated with primary antibody at 2μg/ml for 1 hour at 23°C. The secondary antibody used was a goat anti-mouse IgG conjugated to Alexa Fluor® 350 (blue) used undiluted.p84 shows nuclear localization.
This image was generated using the ascites version of the product.
This image is a courtesy of an anonymous Abreview
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
ICC/IF image of ab487 stained HepG2 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab487, 5μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
This image was generated using the ascites version of the product.
- IP
Supplier Data
Immunoprecipitation - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
Nuclear Matrix Protein p84 was immunoprecipitated from HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate with 3 μg ab487. Western blot was performed from the immunoprecipitate using ab487. Anti-Rabbit IgG was used as a secondary reagent.
Lane 1 : HepG2 whole cell lysate 30 μg.
Lane 2 : Control IP in HepG2 whole cell lysate with 3 μg of pre-immune mouse IgG.
Lane 3 : ab487 IP in HepG2 whole cell lysate.
This image was generated using the ascites version of the product.
All lanes:
Immunoprecipitation - Anti-Nuclear Matrix Protein p84 antibody [5E10] (ab487)
Predicted band size: 76 kDa
false
- WB
Supplier Data
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
7.5% SDS-PAGE gel.
This image was generated using the ascites version of the product.
All lanes:
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (ab487) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 30 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) nuclear lysate at 30 µg
Secondary
All lanes:
HRP-conjugated anti-mouse IgG
Predicted band size: 76 kDa
false
- WB
Supplier Data
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
All lanes:
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (ab487) at 1/1000 dilution
All lanes:
Mouse cerebellum tissue lysates at 50 µg
Secondary
All lanes:
anti-mouse IgG HRP-conjugated antibody
Predicted band size: 47 kDa,50 kDa,68 kDa,70 kDa,71 kDa,73 kDa,74 kDa,76 kDa,77 kDa,78 kDa,80 kDa,82 kDa,88 kDa,90 kDa
false
- WB
Supplier Data
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (AB487)
All lanes:
Western blot - Anti-Nuclear Matrix Protein p84 antibody [5E10] (ab487) at 1/1000 dilution
Lane 1:
HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 2:
HEK-293T whole cell lysate at 10 µg
Lane 3:
HEK-293T whole cell lysate at 5 µg
Secondary
All lanes:
anti-mouse IgG HRP-conjugated antibody
Predicted band size: 76 kDa
false
Related conjugates and formulations (1)
-
578 PE
PE Anti-CD90 / Thy1 antibody [5E10]
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Nuclear Matrix Protein p84 assists in nuclear architecture maintenance and organization. It takes part in DNA replication processes and gene regulation by interacting with chromatin and transcription factors. Furthermore p84 contributes to the formation of the ribonucleoprotein complex facilitating RNA processing and transport. This involvement in multiple nuclear tasks positions it as a critical player in gene expression regulation mechanisms.
Pathways
Nuclear Matrix Protein p84 influences vital cellular activities such as the cell cycle and DNA repair. Its connections are apparent in the regulation of the p53 signaling pathway where it interacts with several regulatory proteins to monitor cell cycle progression and stress responses. p84’s activity also aligns with the DNA damage response pathway highlighting its cooperation with checkpoint proteins like ATM and ATR that uphold genomic integrity during cellular stress conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (105)
Recent publications for all applications. Explore the full list and refine your search
International journal of medical sciences 22:3839-3853 PubMed41049446
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 99:e0220324 PubMed40130877
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of medical sciences 22:460-472 PubMed39781521
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:6052-6075 PubMed39433902
2024
Applications
Unspecified application
Species
Unspecified reactive species
Immunity 57:1124-1140.e9 PubMed38636522
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109245 PubMed38439973
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of pineal research 76:e12921 PubMed37846173
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107617 PubMed37664594
2023
Applications
Unspecified application
Species
Unspecified reactive species
FEBS letters 597:947-961 PubMed36856012
2023
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 18:e0282117 PubMed36821545
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com